Table 3 Summary of the frequency and distribution of diagnostic components for MetS at baseline (Pre), midway (Mid), and completion (Post) of the 1-year experimental period in Control and Yoga groups
Control group (n=98 for PP, n=137 for ITT) | Yoga group (n=84 for PP, n=146 for ITT) | P-value | Effect size | P-value | Effect size | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Age | 55.7 ± 9.4 (range 37 to 77) years | 56.3 ± 8.8 (range 38 to 75) years | (PP) | (PP) | (ITT) | (ITT) | ||||
No. of subjects recovered from MetS after 1-yr (i.e., < 3 components) | 34 | 37 | 0.197 | 0.061 | 0.150 | 0.064 | ||||
No. of subjects had increased no. of MetS components after 1-yr | 13 | 13 | 0.026* | 0.146 | 0.020* | 0.134 | ||||
No. of subjects had unchanged no. of MetS component after 1-yr | 35 | 15 | ||||||||
No. of subjects had decreased no. of MetS components after 1-yr | 50 | 56 | ||||||||
Pre | Mid | Post | Pre | Mid | Post | |||||
No. of subjects had 0 MetS component | 0 (0%) | 1 (1.0%) | 4 (4.1%) | 0 (0%) | 1 (1.2%) | 4 (4.8%) | - | - | - | - |
No. of subjects had 1 MetS component | 0 (0%) | 8 (8.2%) | 9 (9.2%) | 0 (0%) | 10 (11.9%) | 11 (13.1%) | - | - | - | - |
No. of subjects had 2 MetS components | 0 (0%) | 25 (25.5%) | 21 (21.4%) | 0 (0%) | 16 (19.1%) | 22 (26.2%) | - | - | - | - |
No. of subjects had 3 MetS components | 55 (56.1%) | 26 (26.5%) | 32 (32.6%) | 50 (59.5%) | 35 (41.7%) | 26 (31.0%) | - | - | - | - |
No. of subjects had 4 MetS components | 32 (32.6%) | 30 (30.6%) | 25 (25.5%) | 26 (31.0%) | 21 (25.0%) | 20 (23.8%) | - | - | - | - |
No. of subjects had 5 MetS components | 11 (11.2%) | 8 (8.2%) | 7 (7.1%) | 8 (9.5%) | 1 (1.2%) | 1 (1.2%) | - | - | - | - |
No. of subjects had central obesity | 93 (94.9%) | 77 (78.6%) | 80 (81.6%) | 76 (90.5%) | 66 (78.6%) | 54 (64.3%) | 0.018** | 0.145 | 0.279 | 0.378 |
No. of subjects had high systolic blood pressure | 61 (62.2%) | 54 (55.1%) | 49 (50.0%) | 52 (61.9%) | 43 (51.2%) | 40 (47.6%) | 0.497 | 0.045 | 0.463 | 0.358 |
No. of subjects had high diastolic blood pressure | 41 (41.8%) | 36 (36.7%) | 33 (33.7%) | 39 (46.4%) | 25 (29.8%) | 27 (32.1%) | 0.428 | 0.063 | 0.491 | 0.346 |
No. of subjects had elevated fasting plasma glucose | 48 (49.0%) | 42 (42.9%) | 34 (34.7%) | 43 (51.2%) | 38 (45.2%) | 32 (38.1%) | 0.644 | 0.034 | 0.512 | 0.359 |
No. of subjects had elevated fasting plasma triglycerides | 72 (73.5%) | 60 (61.2%) | 60 (61.2%) | 52 (61.9%) | 48 (57.1%) | 42 (50.0%) | 0.758 | 0.019 | 0.372 | 0.362 |
No. of subjects had low plasma HDL-cholesterol | 67 (68.4%) | 55 (56.1%) | 55 (56.1%) | 57 (67.9%) | 46 (54.8%) | 44 (52.4%) | 0.580 | 0.035 | 0.479 | 0.350 |